Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Central monitoring helps sponsors to proactively identify and remediate data quality issues during the conduct of...
Source: Applied Clinical Trials
- Featured Article
CluePoints, a company providing risk-based study execution (RBx) and risk-based quality management (RBQM) software for clinical...
Source: OutsourcingPharma
- Press Release
King of Prussia, PA – October 17, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical...
Source: DIA
- Featured Article
Artificial intelligence (AI) has massive potential to advance clinical research.
...Source: DIA
- Press Release
King of Prussia, PA – October 12, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
At the recent DIA 2023 Global Annual Conference, I focused my attention on discussions about the...
Source: Clinical Research News
- Featured Article
CluePoints Co-Founder and Chief Product & Technology Officer François Torche discusses the challenges of collecting clinical...
Source: DIA
- Featured Article
A conversation with Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts...
Source: Clinical Leader
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Press Release
King of Prussia, PA – August 9, 2023: CluePoints, the premier provider of Risk-Based Study Execution...
- Featured Article
Risk-based quality management (RBQM) is used to identify and assess risks then finding ways to manage...
Source: OutsourcingPharma
- Press Release
Arena International’s flagship event, Outsourcing in Clinical Trials New England, is almost upon us. This year’s...
- Press Release
Wayne, PA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
The 10th Annual FDA/ADVAMED Medical Devices and Diagnostics Statistical Issues Conference, taking place on April 26,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
The Central Monitoring Workgroup will feature speakers from several solution providers who will each present and...
- Press Release
We’re thrilled to announce that version 1.11.0 of CluePoints’ Central Monitoring platform, the enabling SaaS platform...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring solutions for clinical trials, today announced...
- Press Release
We’re thrilled to announce that CluePoints has been named as finalists for the Clinical Informatics News...
- Press Release
The 8th Annual SCOPE Summit for Clinical Ops Executives, taking place on January 24-26, 2017 in...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) and Risk-Based Monitoring(RBM) solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM)...
- Press Release
Cambridge, MA – FDA and its stakeholders have an interest in assuring the integrity of clinical...
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
CluePoints is continuing to invest in artificial intelligence (AI) and machine learning (ML) they say they...
Source: Outsourcing Pharma
- Featured Article
With the clinical trial landscape continuing to evolve and adapt, OSP took the opportunity to speak...
Source: Outsourcing Pharma
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
- Featured Article
Central monitoring, which typically includes the use of key risk indicators (KRIs), aims at improving the...
Source: Springer Link
